| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 07/28/2005 | DE10359796A1 3,4-Dioxythiophen-Derivate 3,4-dioxythiophene derivatives |
| 07/28/2005 | CA2551495A1 Conjugated small molecules |
| 07/27/2005 | EP1557420A1 Process for producing optically active sulfoxide |
| 07/27/2005 | EP1557419A1 Pyrrole derivative and process for producing the same |
| 07/27/2005 | EP1556402A2 In vivo gene silencing by chemically modified and stable sirna |
| 07/27/2005 | EP1556385A1 Heterocyclocarboxamide derivatives |
| 07/27/2005 | EP1556053A1 Antiinflammation agents |
| 07/27/2005 | EP1556047A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 07/27/2005 | EP1313736B1 Condensed pyrazindione derivatives as inhibitors of pde5 |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | CN1646118A Pharmaceutical composition for preventing or treating respiratory disease |
| 07/26/2005 | US6921772 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 07/26/2005 | US6921764 Treating neurodegenerative, psychotropic, and drug and alcohol induced central and peripheral nervous system disorders. |
| 07/21/2005 | WO2005066183A1 Spirocyclic cyclohexane derivatives with affinity for the orl1-receptor |
| 07/21/2005 | WO2005066182A1 Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group |
| 07/21/2005 | US20050159476 Pharmaceutical composition for preventing or treating respiratory disease |
| 07/21/2005 | US20050159475 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 07/21/2005 | US20050159431 Substituted alkyl uracils and thereof |
| 07/21/2005 | US20050159408 Heating a reaction mixture of N-methylpiperazine and thienobenzodiazepine to 110 to 145 degrees C |
| 07/21/2005 | US20050158782 Magnetic fine particles having lower critical solution temperature |
| 07/21/2005 | CA2552598A1 Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group |
| 07/20/2005 | EP1554299A2 Novel pentose derivatives as anti-hyperglycemic drugs |
| 07/20/2005 | EP1554284A1 Method for manufacturing crystalline form i of clopidogrel hydrogen sulphate |
| 07/20/2005 | EP1305305A4 Hyperpolarizable organic chromophores |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | CN1642959A Novel dithiolopyrrolones with therapeutic activity |
| 07/20/2005 | CN1642940A Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides |
| 07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642752A Optical recording media and dipyrromethene-metal chelate compounds |
| 07/20/2005 | CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 07/20/2005 | CN1211362C New benzothiophene, benzofuran and indole compounds, process for their preparation and pharmaceutical compounds containing them |
| 07/19/2005 | US6919367 Substituted thioacetamides |
| 07/19/2005 | US6919358 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/19/2005 | US6919179 Generating labeled proteins; obtain nucleotide sequences, incubate with cell free translation system, recover labeled protein |
| 07/14/2005 | WO2005063828A1 Metallocene compounds |
| 07/14/2005 | WO2005063771A1 Methods of preparing olanzapine |
| 07/14/2005 | WO2005063769A1 Spirocyclic cyclohexane derivatives |
| 07/14/2005 | WO2005063712A1 5-ht2 receptors modulators, their pharmaceuticals compositions and their use for the treatment of cardiovascular and muscle diseases |
| 07/14/2005 | WO2005063708A2 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate |
| 07/14/2005 | WO2005063241A1 Preventive and/or therapeutic agent for disease in which mitochondrial benzodiazepine receptor participates |
| 07/14/2005 | WO2005049579A3 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/14/2005 | WO2004048386A9 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS |
| 07/14/2005 | US20050154202 Substituted aryl amides |
| 07/14/2005 | US20050154008 Aryl fused substituted 4-oxy-pyridines |
| 07/14/2005 | US20050153954 Stirring polymorphic olanzapine in 1-butanol or tert-butanol; isolating solid; drying |
| 07/14/2005 | US20050153371 Conjugated small molecules |
| 07/14/2005 | CA2676121A1 Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate |
| 07/14/2005 | CA2551806A1 Methods of preparing olanzapine |
| 07/14/2005 | CA2551552A1 5-ht2 receptors modulators, their pharmaceuticals compositions and their use for the treatment of cardiovascular and muscle diseases |
| 07/13/2005 | EP1553098A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 07/13/2005 | EP1553085A1 Cyclic amine derivatives and their use as drugs |
| 07/13/2005 | EP1551848A1 Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 07/13/2005 | EP1551847A1 3,4-alkylenedioxythiophene compounds and polymers thereof |
| 07/13/2005 | EP1551822A2 Pentacyclic oxepines and derivatives thereof, process for their preparation and pharmaceutical compositions containing them |
| 07/13/2005 | EP1551414A2 Crystal forms of olanzapine and processes for their preparation |
| 07/13/2005 | EP1235802B1 Carbamate derivatives having muscarinic receptor antagonist activity |
| 07/13/2005 | EP1171443B1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 07/13/2005 | EP1042291B1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 07/13/2005 | CN1639168A Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 07/13/2005 | CN1639167A Heterocyclic amide derivatives having glycogen phosphorylase inhibitory activity |
| 07/13/2005 | CN1636996A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands |
| 07/13/2005 | CN1636990A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/12/2005 | US6916830 Substituted tetrahydroisoquinolines as C5a receptor modulators |
| 07/07/2005 | WO2005061518A1 Mitotic kinesin inhibitors |
| 07/07/2005 | WO2005061500A1 Spiropiperidine derivatives for controlling pests |
| 07/07/2005 | WO2005061477A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | WO2005012310A8 Use of thienopyridine compound in perfume and novel thienopyridine compound |
| 07/07/2005 | WO2004058704A3 Quinazolinones as potassium channel modulators |
| 07/07/2005 | WO2004048927A3 Second order nonlinear optical chromophores, polymers containing same, and electro-optic devices therefrom |
| 07/07/2005 | US20050148610 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 07/07/2005 | US20050148605 Modulation of protein tyrosine kinases for treatment of diseases with prodrugs |
| 07/07/2005 | US20050148603 Compositions useful as inhibitors of protein kinases |
| 07/07/2005 | US20050148593 Compounds, compositions, and methods |
| 07/07/2005 | US20050148579 Industrial scale synthesis, work up, purification and isolation without giving off foul smelling and/or toxic by products; sedatives; one pot process |
| 07/07/2005 | US20050148578 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148577 2-methyl-1,8-dioxa-dibenzo[e,h]azulene; potentiation; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury |
| 07/07/2005 | CA2548518A1 Biaryl sulfonamides as mmp inhibitors |
| 07/07/2005 | CA2547814A1 Spiropiperidine derivatives for controlling pests |
| 07/07/2005 | CA2547746A1 Mitotic kinesin inhibitors |
| 07/06/2005 | EP1549655A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 07/06/2005 | EP1549654A1 Process and intermediates for the preparation of thienopyrrole derivatives |
| 07/06/2005 | EP1549653A1 Process and intermediates for the preparation of thienopyrrole derivatives |
| 07/06/2005 | EP1549646A2 Piperidine derivatives |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | CN1636001A 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
| 07/06/2005 | CN1635979A IL-8 receptor antagonists |
| 07/06/2005 | CN1635903A Protease inhibitors |
| 07/06/2005 | CN1634927A Spirofluorene materials containing non-benzene aromatic ring and synthesis and use thereof |
| 07/05/2005 | US6913710 Reactive mesogenic benzodithiophenes |
| 07/05/2005 | CA2220509C Fused polycyclic heterocycle derivatives |
| 07/05/2005 | CA2072541C Heterocyclic compounds, their production and use |
| 06/30/2005 | WO2005058857A1 Tetronic and tetramic acids as inhibitors of beta-secrease |
| 06/30/2005 | WO2005058836A1 Insecticidal spiroindane derivatives |
| 06/30/2005 | WO2005058494A1 Novel multicomponent oxidation catalyst and process for producing epoxy compound therewith |
| 06/30/2005 | WO2005058315A1 Novel heterocyclic compounds as ikk2 inhibitors with anti-hbv activity |
| 06/30/2005 | WO2005020293A3 Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |